Decorations and Inclusions Market Poised for 5.9% CAGR Growth through 2033: FMI Report

Picture background

The decorations and inclusions market is expected to increase from USD 10.6 billion in 2023 to USD 18.8 billion in 2033.

Rising Demand for Bakery and Confectionery to Propel Market Growth

Bakery and confectionery items, such as cakes, cookies, and others, are widely consumed worldwide. As a result, these products are widely utilized in cookies, cakes, and other confectionary products, fueling industry growth. Furthermore, decorations and inclusions are utilized in various bakery items to add flavor and texture while making the product more appealing and presentable, contributing to industry growth over the projection period.

The global business was unaffected by the pandemic because demand for these products increased due to the closure of commercial establishments such as bakeries, specialist cake shops, ice cream stores, and others. In addition, individuals all around the world were spending most of their time at home and experimenting with various varieties of cookies, cakes, pastries, and other baked goods utilizing these materials.

This expanded the use of decorations and additions at home, driving industry expansion during the pandemic. Cakes, pastries, confectionaries, cookies, and other food products are among the most popular and consumed around the world. Decoration and inclusion products are widely utilized in these products, promoting the market growth.

With the growing trend of personalizing pastries, desserts, and cakes, these items are being utilized more frequently, projected to boost the industry’s growth. Furthermore, such products are available in various designs, sizes, and shapes to choose from, providing a unique finish and style to the final dishes while also being versatile and usable in various seasons and situations.

Key Points from the Decorations & Inclusions Market

  • The rising demand for textured and decorative baked goods, as well as the expansion of bakery and confectionery sectors across regions, are expected to fuel the growth of the decorations & inclusions market.
  • The decorations & inclusions market is expected to record a CAGR of 5.9% during the forecast period 2023 to 2033.
  • North America dominated the decorations & inclusions market

Key Development in the Decorations & Inclusions Market

Barry Callebaut announced the acquisition of Europe Chocolate Company in September 2021. (ECC). This acquisition is expected to aid Barry Callebaut’s manufacturing skills in the highly specialized chocolate decorations and speciality industry.

  • In May 2021, Cargill announced the acquisition of Leman Decorating Company, a renowned provider of cake decorations. The corporation implemented the approach to serve Europe’s gourmet clients better and increase Cargill’s decorative options globally.
  • In May 2019, Pecan Deluxe Candy Company revealed that it had invested around US$ 3.93 million in developing its custom-built streamlining procedures and production facilities.
  • In October 2018, with increased consumer demand for cleanly labeled natural products, the Paulaur Corporation announced non-GMO certified dessert covering.
  • In August 2022, according to a survey by Pushups, LLC, 62% of Americans favor chocolate chip cookies above others, making it one of the most popular flavors among customers. As a result, the high preference, consumption, and integration of these items in various products are expected to drive market expansion over the projection period.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/decorations-and-inclusions-market

Key Segment

By Product Type:

  • Chocolate Sprinkles and Inclusions
  • Chocolate Shapes
  • Chocolate Cups and Shells
  • Sugar Sprinkles and Inclusions
  • Sugar Shapes
  • Preserved/Dried Fruit Pieces
  • Sweetened/Caramelized Nuts
  • Roasted Nuts
  • Baked Pieces
  • Sugar Pastes & Icings

By End Use:

  • Industrial/Food and Beverage Processing
    • Baked Goods
  • Cakes
  • Pastries
  • Sweet Biscuits
  • Breakfast Cereals
  • Confectioneries
  • Chocolate Confectioneries
  • Sugar Confectioneries
    • Ice Cream and Frozen Desserts
    • Snack Bars
  • Bakeries and Pastry Shops
  • Confectionery Shops
  • Restaurants and Hotels
  • Household (Retail)

By Sales Channel:

  • Direct Sales/Business-to-business
  • Indirect Sales/Business-to-consumers
  • Intermediate/Bulk Distributors
  • Brick & Mortar Retailers
  • Online Retailers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Vanilla Bean Market Estimated to Reach USD 1.93 Billion by 2033: Industry Analysis

Picture background

During the forecast period, the vanilla bean market is expected to grow at a 4.4% average CAGR. In 2023, the market is anticipated to have a share of USD 1.26 billion. By 2033, it is projected to reach a value of USD 1.93 billion.

Vanilla is widely used in the food and beverage industries as a flavouring for jams, jellies, and syrup. Vanilla’s antibacterial properties make it ideal for cleaning and mending damaged skin. Vanilla can help with symptoms of anxiety and depression.

It’s worth mentioning that the lowest-wage countries were selected since vanilla production requires a large workforce. Madagascar produces approximately 3000 tons of vanilla per year, according to the FAO. Uganda produced 150 tones in 2018. Vanilla is grown in the rural Comoros as well.

Future Market Insights’ most recent market report, “Vanilla Bean Market,” included these startling statistics as well as future projections. Analysts and consultants in this area have thoroughly explored the bottom-up strategy.

Key Takeaways from Vanilla Bean Market

  • Hawaiian vanilla could be recognized through presence of topical aroma with a tinge of caramel.
  • France-based vanilla bean makes way for a broad spectrum of certified Kosher, Halal, Organic, and Fairtrade products that match specifications needed at the commercial level; like vanilla powders’ fineness, solubility, and aromatic profiles. There are players like Eurovanille, which have been setting benchmark for more than 3 decades in vanilla bean market all over France. The productions, since the year 2014, have been certified by IFS (International Featured Standard) for ascertaining healthy and safe product.
  • Mexico is amongst the major cultivator of vanilla beans. This could be credited to symbiotic relationship that vanilla orchid and Melipona enjoy. It is a known fact that the Mexican bee mentioned above is the only one capable of pollinating vanilla orchid flower. Nielsen-Massey Vanillas, Inc. is making provisions for the product with Kosher and also holds the distinction of being free of gluten.
  • Madagascar vanilla beans are categorized as the ‘gold standard’ regarding quality. Also, they have vanillin in higher concentrations as compared to their counterparts.

Competitive Beans

  • Tahitian Gold Co., Inc., in January 2020, announced to come up with 3-Bean Blend. It’s a whole vanilla bean paste that the company is offering.
  • Eurovanille, in the year 2019, did announce building 1K m2 experimental greenhouse at Gouy-Saint-Andre, so as to characterize 2K vanilla plants in sync with genome study as well as decryption, which would be the scientific publication project (the company claims). Also, the year 2022 is into witnessing plant selection.
  • Symrise AG does use bourbon vanilla beans for making pure vanilla extract. These beans are long and slender, which do have a good taste, inclusive of dried fruit, rum, and raisins.

“Vanilla bean is abreast with anti-carcinogenic and anti-oxidant properties, which renders it useful in cosmetics, food & beverage, and pharmaceutical vertical”, says an analyst from Future Market Insights.

What does the Report Cover?

  • The research study is based on nature (conventional and organic), by form (whole and extract), by origin type (Indonesian, Madagascar, Mexican, Ugandan, Tahitian, and likewise), by sales channel (B2B/HoReCa, and B2C (hypermarkets/supermarkets, convenience stores, mom and pop stores, discount stores, food & drink specialty stores, independent small groceries, online retail, and others), and by application (food and beverages industry (bakery, confectionery, cheese & dairy, desserts, baby food, breakfast solutions, powder premixes, alcoholic beverages, and non-alcoholic beverages), nutritional supplements, pharmaceuticals, cosmetics & personal care, animal feed, household items, and others).
  • With vanilla bean being looked upon as one of the signature ingredients in hordes of products all across, the global vanilla bean market is likely to grow on a voracious note in the near future.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/vanilla-bean-market

Frequently Asked Questions

How much worth is the vanilla bean industry?
At what CAGR is the market expected to expand through 2032?
How was the performance of vanilla bean over the past half-decade?
What will be the market for vanilla bean worth in 2032?
Who are the key players operating in the market?
Which are the top countries driving the vanilla bean market demand?
What are the key factors affecting the vanilla bean market growth?

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Foaming Creamer Market to Witness 3.6% CAGR Growth by 2033 amid Rising Clean Label Trends

Picture background

The foaming creamer market is predicted to be worth USD 176.7 million in 2023 and rise to USD 251.4 million by 2033. Initially, the global market expanded at a CAGR of 3.3% between 2017 and 2022.

Due to the rising demand for organic and healthy food products, several potentials exist for the foamy creamer powder market to flourish. In addition, customers are looking for food products with clear labeling due to rising health-related concerns. As a result, there is a steady increase in demand for foamy creamer.

Manufacturers of foaming creamer make specific claims, have certifications, and use specific labeling to help consumers form a favorable perception of their products. Foaming Creamer is being used more frequently due to the expanding coffee market.

Global coffee consumption has increased in recent years. The forecast period is expected to show a slight increase in demand for coffee and additions such as foamy creamers, particularly in emerging nations.

Key Takeaways

  • By 2033, China is likely to dominate the foaming creamer market, with a size of US$ 19.5 million.
  • The foaming creamer market was significantly expanding, with a size of US$ 170.5 million in 2022.
  • There is a market opportunity of US$ 74.7 million in absolute terms, driven by the demand for vegan items.
  • The market in the United States is anticipated to expand at an adequate CAGR of 3.9% by 2033.
  • By 2033, Canada is likely to expand in the foaming creamer sector, with a size of US$ 16.3 million.
  • By 2033, the foaming creamer sector is likely to increase in Poland, with a size of US$ 8.3 million.
  • The market in the Netherlands is anticipated to expand at an adequate CAGR of 2.7% by 2033.
  • With a CAGR of 3.3% by 2033, the dairy foaming creamer category is predicted to dominate the market in terms of base.
  • Based on function, the instant segment continues to dominate the sector during the forecast period, with a CAGR of 4%.

Key Strategies in the Industry

As the rate of technological improvements in the food equipment industry heats up, the market is seeing growth in new, more technologically advanced devices and equipment. As a result, businesses that make foaming creamer are largely focused on strategies that enable them to increase their market share.

Players in the foaming creamers production scenario market include FrieslandCompania Kievit, Super Group Ltd., Suzhou Jiahe Foods Industry, Santho Holland Food B.V., Custom Food Group, Viceroy Holland B.V., and Shandong Tianjiao Biotech. These companies also frequently engage in product launches, mergers and acquisitions, joint ventures, and geographic expansion.

Recent Developments

  • One of the top producers of beverages and food products in the world, Friesland Campina Kievit, created a new line of foaming creamers in 2017 that rapidly turned an Italian-style meal into a luxurious experience. Nowadays, consumers may prepare coffee-type drinks like a cappuccino whenever and wherever they desire.
  • The factory of Fujian Jumbo Grand Food Co. Ltd. has built three cutting-edge worldwide production lines to make premium non-dairy creamers.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/foaming-creamer-market

Key segments

By Base:

  • Dairy
  • Non-Dairy

By End Use:

  • Beverage Mixes
    • Coffee-based Mixes
    • Milk Tea Mixes
    • Cocoa-based Mixes
  • HoReCa/Foodservice
  • Dietary Supplements

By Function:

  • Instant
  • Cold Water Soluble

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • ASEAN
  • China
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Global Precocious Puberty Treatment Market to Reach USD 3,650.66 Million by 2033, Driven by Regulatory Approvals and Strategic Partnerships: FMI Study

The global precocious puberty treatment market is on a remarkable growth trajectory, with an estimated valuation of USD 1,716.43 million in 2023, projected to nearly double to USD 3,650.66 million by 2033, reflecting a robust CAGR of 7.8% during the forecast period.

Key Drivers of Market Growth:

  1. Regulatory Approvals Propelling Market Expansion:

Industry players are increasingly focusing on securing product approvals from regulatory bodies such as the United States Food and Drug Administration (FDA). This strategy is expected to significantly drive market growth. For instance, in May 2020, Tolmar Pharmaceuticals, Inc. obtained FDA approval for its New Drug Application for FENSOLVI® (leuprolide acetate), an injectable suspension for treating pediatric patients aged two years and older with precocious puberty.

  1. Strategic Collaborations Strengthening Market Position:

Companies are adopting inorganic growth strategies, such as partnerships, mergers, and distribution agreements, to enhance their market presence. A notable example is the January 2016 agreement between Debiopharm International SA and Arbor Pharmaceuticals for the exclusive distribution of triptorelin 22.5 mg for treating Central Precocious Puberty.

  1. Innovative Research and Development Efforts:

Research activities surrounding triptorelin for various therapeutic applications are accelerating market growth. Triptorelin’s high efficacy and tolerability in suppressing gonadotropin secretion have increased its adoption for treating both precocious puberty and prostate cancer.

  1. Geographical Expansion and Product Availability:

Key players are expanding their product portfolios into new geographical regions. In October 2017, Arbor Pharmaceuticals and Debiopharm International SA launched Triptodur® (triptorelin) in the United States, offering a critical treatment option for pediatric patients diagnosed with precocious puberty.

  1. Reimbursement Policies Enhancing Accessibility:

Financial support for precocious puberty treatments through Medicaid programs is expected to create lucrative growth opportunities, making these treatments more accessible to patients worldwide.

Future Outlook

The precocious puberty treatment market is poised for sustained growth, driven by innovative product developments, strategic partnerships, and an increasing focus on regulatory compliance. With key players investing in R&D and expanding their geographical reach, the market is well-positioned to meet the growing demand for effective treatment options.

Key Takeaways from the Market Study:

  • North America is expected to dominate the industry while reaching market share of around 46.7% by end of the forecast period.
  • The market in East Asia is projected to account for 25% market share by end of the projected period.
  • By drug class, ‘triptorelin’ is projected to account for 62% market share by end of the forecast period.
  • Hospitals are expected to dominate the market by distribution channel, with a market share of 58% by 2033.

“Increasing rate of product approvals, surging growth in mergers and acquisitions between companies, and development of new drugs will increase the product demand for treatment of precocious puberty,” comments an FMI analyst.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape:

The precocious puberty treatment market is extremely competitive and consists of various key market players. These players are developing novel delivery systems for treating precocious puberty. This is anticipated to fuel precocious puberty treatment market. The key players in this market are: Teva Pharmaceutical Industries Ltd, AbbVie Inc., Arbor Pharmaceuticals, LLC, Pfizer Inc, Tolmar Pharmaceuticals, Inc., Endo International plc, Ipsen Pharma, Debiopharm Group, Sun Pharmaceutical Industries Limited, Sanofi

Key industry players are inclined on adoption of inorganic growth strategies like acquisition, partnerships, and collaboration in order to bolster their product portfolio. This is expected to propel the global precocious puberty treatment market.

  • In June, 2020, Ipsen Pharma undergone strategic partnership with Debiopharm for Decapeptyl (triptorelin) for another 15 years. Decapeptyl (triptorelin) is used for treating central precocious puberty in children. This strategic merger helped the company to maintain a continuous product access to patients.
  • In March 2022, Accord BioPharma, the United States special division of Intas Pharmaceuticals, Ltd. declared the United States launch of CAMCEVI (leuprolide) 42mg injection emulsion for the treatment of progressive prostate cancer in adults.In February 2022, BDR Pharmaceuticals revealed its brand ENZALUTAMIDE, an antiandrogen in 160mg with brand name BDENZA for  treatment of Prostate Cancer patients.
  • In January 2019, Debiopharm group informed about an agreement with Allergan to begin a transition process for Trelstar (Triptorelin pamoate) intended to lead to new licensees taking over the commercialization of Trelstar in the United States and Canada and the termination of Allergan’s partnership with Debiopharm for strategic reasons.

Key Segments Profiled in the Precocious Puberty Treatment Industry Survey:

By Drug Class:

  • Leuprorelin
  • Histrein
  • Triptorelin
  • Nafarelin

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

mRNA Sequencing Industry

Non-Invasive Respiratory Monitoring Industry

At-Home Cancer Testing Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Hybrid Rice Seeds Market Forecast to Exceed USD 10.8 Billion by 2033: FMI Insights

Hybrid Rice Seeds Market

The hybrid rice seeds market  is predicted to be worth USD 5.1 billion in 2023, and rise to USD 10.8 billion by 2033. Initially, the global market was expanding at a CAGR of 7% between 2017 and 2022.

Many abiotic and biotic factors present a barrier to sustainable rice agriculture. As a result, stress tolerance has been included into high-yielding varieties, which has shown to be a very successful method for creating these varieties that can handle such circumstances. This is boosting the hybrid rice seeds market and reducing the losses brought on by stress-related issues.

The development of hybrid rice seeds that are resistant to microbial infestations and produce larger yields in a relatively short amount of time than inbred types is another focus for hybrid seed producers, which is expected to fuel expansion.

Since rice is a staple food for around 60% of the world’s population, the demand for it is rising along with the worldwide population. In order to meet this rising demand and supply rice to various end users, rice yield per unit area has also increased.

To develop new hybrid rice seeds varieties and encourage farmers to use them, the government and numerous research institutions are working together.

Key Takeaways

  • By 2033, China is likely to dominate the hybrid rice seeds market, with a size of US$ 4.3 billion.
  • The hybrid rice seeds market was significantly expanding, with a size of US$ 4.8 billion in 2022.
  • There is a market opportunity of US$ 5.7 billion in absolute terms, which is driven by the change in consumption patterns.
  • The market in the United States is anticipated to expand at an adequate CAGR of 3.7% by 2033.
  • By 2033, Canada is likely to expand in the hybrid rice seeds market, with a size of US$ 75.6 million.
  • By 2033, the hybrid rice seeds sector is likely to increase in Japan, with a size of US$ 176.2 million.
  • The Indian market is anticipated to expand at an adequate CAGR of 8.8% by 2033.
  • Based on grain size, the long grains led the hybrid rice seeds market with a CAGR of 6.2% by 2033.
  • Based on duration, up to 110 days segment continues to dominate the sector during the forecast period, with a CAGR of 8.4%

Key Strategies in the Industry

Due to the rising need for bigger yields and better-quality produce, hybrid rice seed technology has experienced substantial expansion in the last few years. In order to gain market share in the fiercely competitive market for hybrid rice seeds, businesses must offer better variety, affordable prices, and aggressive marketing.

To remain ahead of the competition, businesses are developing new types and technologies. To reach more clients, they are also concentrating on marketing and advertising initiatives. In order to expand their reach, businesses are also concentrating on enhancing their distribution networks and opening new stores.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/hybrid-rice-seeds-market

Recent Developments

  • Ricetec Inc. purchased the assets of Ganga Kaveri Seeds in 2019 to expand its product line and draw in more clients.
  • As of May 2019, Syngenta has released the SYN98 3-line hybrid rice variety in Vietnam. The Syngenta Nam Dinh Research Center has been given approval by the Ministry of Agriculture and Rural Development to start trial production of this variety in December 2017.

Key Segments

By Grain Size:

  • Long Grains
  • Medium-sized Grains
  • Short Grains

By Durability:

  • Up to 110 Days
  • 111 to 140 Days
  • 140+ Days

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Ginseng Market Valuation to Climb to USD 1,262.3 Million by 2034

Ginseng Market

The global ginseng market share value is projected to total USD 786.3 million in 2024 and USD 1,262.3 million by 2034. Demand for ginseng will likely increase at a steady CAGR of 4.3% throughout the forecast period.

Ginseng demand remains high in the pharmaceutical sector due to its potential health benefits. As per the latest analysis, the pharmaceutical products segment is estimated to hold a market share of 41.8% in 2024.

Multiple factors are anticipated to drive the ginseng industry forward during the assessment period. These include:

  • The multifunctional attributes of ginseng
  • Growing health consciousness among consumers
  • Rising interest in herbal supplements
  • Increasing demand for ginseng-based products
  • Continuous innovation in ginseng products

Today, consumers are increasingly seeking natural and organic products. As a result, there is a growing demand for herbal products like ginseng. This will continue to provide impetus for the growth of the ginseng market during the assessment period.

The varied applications of ginseng, encompassing its adaptogenic properties, immune system support, and potential cognitive benefits, are creating a robust demand among consumers seeking natural and holistic approaches to health. This trend is likely to persist as the awareness of ginseng’s health benefits continues to grow.

Ongoing scientific research into the medicinal properties of ginseng, including its potential impact on stress, immunity, and cognitive function, is contributing to the credibility and marketability of ginseng-based products. This will support market expansion through 2034.

As more studies highlight the potential health benefits of ginseng, consumers are becoming more confident in incorporating ginseng-based products into their wellness routines. This combination of traditional wisdom, anecdotal evidence, and scientific backing has created a compelling narrative around ginseng, driving its popularity in the health and wellness market.

Advances in extraction and processing techniques are influencing the development of ginseng products. Innovations in these areas may lead to the creation of new and more potent formulations, enhancing the overall appeal of ginseng-based offerings.

Ginseng producers leverage online channels for promotion and sales due to the increasing use of the internet and the simplicity of online transactions among consumers. Online merchants are favored by the majority of consumers, driving businesses to establish a strong online presence.

Key Takeaways from the Ginseng Market Study

  • The global market for ginseng is set to have a total valuation of US$ 1,262.3 million in 2034.
  • Based on source, the cultivated ginseng segment will account for a revenue share of over 7% in 2024.
  • By end-use, pharmaceutical products segment is expected to hold a market share of 8% in 2024.
  • The United States is poised to exhibit a CAGR of 3% through 2034.
  • Ginseng demand in India is projected to grow at a CAGR of 1% from 2024 to 2034.

“The ginseng market is witnessing a transformative shift, propelled by a surge in consumer awareness of its health benefits, including adaptogenic properties and immune system support. Notably, the market is diversifying its product offerings, with manufacturers innovating in supplements, teas, and skincare products to cater to varied consumer preferences,” says a lead analyst at Future Market Insights (FMI).

Who is Winning?

A few of the leading players operating in the ginseng market are Organika Health Products Inc., Daedong Korea Ginseng Co., Ltd., Korean Ginseng Export Corporation, Ilhwa Co. Ltd., Korean Ginseng Corp., Shanghai FanPharma Co., Ltd., RFI Ingredients, Inc., Koshiro Co Ltd, Ningbo Gianon Biotech Co., Ltd., Nature’s Way, Sino-Nature International Co., Ltd., and other players.

Due to the rising consumer demand for ginseng, several leading manufacturers are focusing on offering it at the best possible pricing. They are constantly launching new products in lucrative regions as well as using sustainable farming practices. Many companies also employ strategies like collaborations, partnerships, and acquisitions to stay relevant in the market.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/ginseng-market

Recent Developments:

  • In December 2022, Korea Ginseng Corp. launched Pure Extract Heaven in the United States market to meet the rising demand for herbs and natural source supplements in the nation.

Get Valuable Insights into Ginseng Market Report

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the ginseng industry, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034. The study provides compelling insights based on source (wild, cultivated), form (raw, powder, extract), variety (oriental, American, Siberian, and others), and end-use (personal care products, dietary supplements, food and beverage processing, pharmaceutical products) across seven major regions.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Oat Drink Market Expected to Reach USD 1.68 Billion by 2034

In the recent edition of the oat drink market report, Future Market Insights (FMI) finds growth prospects to go as high as 7.5% from 2024 to 2034. With the emergence of health-conscious consumers, key oat drink manufacturers are investing in the development of gluten-free products. Going by this pattern, demand could expand and equate to a market valuation of USD 1,684.5 million by 2034. Sales of oat drinks hold a current valuation of USD 799.4 million in 2024

The market for oat drinks is growing quickly because of these new, healthier options. Improved oat milk beverages are currently being made by some businesses. Furthermore, manufacturers are using natural sweeteners like honey or agave in place of artificial sweeteners and sugar when making oat beverages. Organic or non-GMO oat drinks are getting more and more well-liked.

Oat cereal drinks are gaining popularity in the oat beverage sector. This trend is influenced by the increase in popularity of plant-based beverages, the creation of oat-based smoothies, and the rise in demand for oat milk. Particularly oat milk has gained popularity because of its nutty flavour and creamy texture. People are exploring oat cereal drinks as a dairy-free substitute due to the growing trend of plant-based drinks.

Key Takeaways

  • By 2033, the United States is likely to dominate the oat drinks market, with a size of US$ 293.6 million.
  • The oat drinks market was significantly expanding, with a size of US$ 689.8 million in 2022.
  • There is a market opportunity of US$ 829.8 million in absolute terms, driven by the clean labels.
  • The expansion in China is anticipated to expand at an adequate CAGR of 9.3% by 2033.
  • By 2033, Australia is likely to expand in the oat drinks market, with a size of US$ 76.6 million.
  • By 2033, the oat drinks sector is likely to increase in Brazil, with a size of US$ 73.4 million.
  • The expansion in the United Kingdom is anticipated to expand at an adequate CAGR of 6.9% by 2033.
  • Based on product type, the regular full-fat segment led the market CAGR of 7.6% by 2033.
  • Based on flavor, the natural/unflavored continues to dominate the sector during the forecast period, with a CAGR of 7.1%

Key Strategies in the Industry

Manufacturers like Oatly are looking for novel methods of milk extraction to establish distinctive selling points and set their products apart from the competition. The end product is more affordable because manufacturers’ direct purchases of premium raw materials from farmers favor market expansion.

Due to the growing set of startups and their increased need for convenience and health benefits, there is an increase in the demand for RTD tea and coffee in the startup market. The oat drinks industry consequently gains from this.

Lastly, the oat drinks sector has seen significant innovation spurred by the development of new technology. Businesses have created goods with better shelf life, enhanced carbonation, and innovative packaging technologies that enable greater customer convenience.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/oat-drinks-market

Recent Developments

  • Pure Harvest Farms collected US$ 180.5 million in June 2022 from international investors to support its growth.
  • Fazer Group purchased Kaslink in June 2019, expanding its lineup of oat-based products on a global scale.

Key segments

By Flavour:

  • Natural/Unflavoured
  • Flavored

By Product Type:

  • Regular/Full Fat
  • Reduced Fat

By End Use Application:

  • Food Services
  • Retail Services

By Nature:

  • Organic
  • Conventional

By Format:

  • Shelf-stable
  • Refrigerated

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Linseed Oil Market Forecasted to Expand at 6% CAGR, Surpassing USD 13.9 Billion by 2033

The linseed oil market is predicted to be worth USD 7,904 million in 2023, and rise to USD 13,972.5 million by 2033. The global industry was expanding at a CAGR of 2.4% from 2018 to 2022.

With the advancement of science and technology, flax plant cultivation is now mostly done for the purpose of pressing linseed oil. It is used in lubricating paints, varnishes, and the leather industry. The aforementioned applications are anticipated to drive cold-pressed flaxseed oil demand during the next ten years.

The market is projected to experience declines during the projection period since linseed oil is dangerous and can start fires. It is also inappropriate for use in infant goods because it irritates the skin and eyes when in touch.

Profitable Market Opportunity

Key important factor anticipated to propel the expansion of the global linseed oil industry is the rising consumption due to its numerous health benefits. Linseed oil’s ALA and omega-3 content helps to lower inflammation, guards against brain aging, and enhances hearth health. Several research aims to show conclusively that linseed oil consumption inhibits the growth of cancer cells. In turn, this is likely to present a profitable chance for market participants.

Key Takeaways

  • By 2033, the linseed oil market in the United Kingdom is likely to expand, with the CAGR of 4.8%.
  • In 2022, the United States expanded effectively in the linseed oil sector, with a share of 8.8%.
  • The linseed oil market was significantly expanding, with a size of US$ 7,600 million in 2022.
  • By 2033, the linseed oil industry in China is likely to expand, with a CAGR of 4.6%.
  • In 2022, Australia projected to expand in the linseed oil business, with an expected share of 2.4%.
  • The market is expected to grow at a US$ 10,719. 87 million valuation by 2028, with rising health awareness.
  • By 2033, India is projected to expand significantly in the linseed oil sector, with a share of 17.9%.
  • Japan’s linseed oil market share expanded significantly, with a 4.2% share in 2022.
  • In 2022, paint & textile dominated the market with a leading share. It is anticipated to control the market by 2033 in terms of application.
  • Based on product type, raw linseed oil is expected to dominate the market during the forecast period.

Effective Approaches by Key Players

The demand for linseed oil is likely to increase as a result of beneficial programs and initiatives launched by governments and producers. Suppliers from several nations worldwide are promoting sophisticated and organic farming practices.

Recent Developments

  • In August 2017, ADM Corporation added green tea, acerola, antioxidants, and mixes of tropical fruit to their plant-based extraction production line. There is a lot of vitamin C and other beneficial components in these products.
  • In September 2021, Croda International Plc. opened the doors to its crop care product validation center in Brazil, strengthening its position in the agricultural industry and promoting product development. This tactical approach is advantageous for the market, because crop care goods utilize it.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/linseed-oil-market

Key Segments

By Nature:

  • Organic Linseed Oil
  • Conventional Linseed Oil

By Product Type:

  • Raw Linseed Oil
  • Boiled Linseed Oil
  • Double-boiled Linseed Oil
  • Other Types

By Application:

  • Dietary Food
  • Pharmaceuticals
  • Paint & Textile Industry
  • Leather Industry
  • Animal Feed
  • Personal Care
  • Processed Food
  • Others

By Distribution Channel:

  • Online Retailers
  • Grocery Stores
  • Wholesalers
  • Supermarkets

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs YouTube

Global Endometrial Ablation Market Set to Reach USD 6.8 Billion by 2033

The global endometrial ablation market is poised for remarkable growth, with revenues estimated at USD 3.4 billion in 2023, and anticipated to nearly double to USD 6.8 billion by 2033, according to a recently published report by Future Market Insights. This growth trajectory represents a CAGR of 7.3% over the forecast period from 2023 to 2033.

Endometrial ablation, a minimally invasive procedure used to treat abnormal uterine bleeding, is witnessing a surge in demand globally. The procedure’s ability to provide an effective alternative to hysterectomy, coupled with advancements in medical technologies, has been driving market expansion.

Key Drivers of Market Growth:

  • Rising Prevalence of Abnormal Uterine Bleeding (AUB): Increasing awareness and diagnosis of AUB have fueled the demand for endometrial ablation procedures.
  • Technological Innovations: Cutting-edge technologies, such as radiofrequency and cryoablation devices, are improving patient outcomes, bolstering adoption rates.
  • Preference for Minimally Invasive Procedures: Patients and healthcare providers alike are increasingly opting for less invasive options due to shorter recovery times and reduced risks compared to traditional surgeries.

Regional Highlights:

The report highlights strong growth potential in both developed and emerging markets. North America and Europe remain key contributors due to advanced healthcare infrastructure and high adoption rates. Meanwhile, emerging markets in Asia-Pacific are projected to exhibit the fastest growth, driven by improving healthcare systems and rising patient awareness.

Outlook:

As the Endometrial Ablation Market progresses, the focus will likely shift towards integrating AI-powered diagnostics and enhancing accessibility in underserved regions. This aligns with global efforts to ensure equitable healthcare solutions for all.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Competitive Landscape:

The key players in the global endometrial ablation market are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc., Olympus Corp., Richard Wolf GmbH, AngioDynamics, Hologic, Inc., and Minerva Surgical, Inc.

A few of the recent developments in the market are:

  • In February 2021, CooperSurgical, a division of CooperCompanies, has acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
  • In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
  • In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division’s worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
  • In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific’s electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company’s offerings.

Market Segments Covered in Endometrial Ablation Market Analysis

By Type:

  • Devices
    • Cryoablation
    • Radiofrequency Ablation
    • Hydrothermal Ablation
    • Thermal Balloon
    • Microwave Energy
  • Procedures

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Attenuated Vaccines Industry

Transcriptomics Technologies Industry

Leukapheresis Products Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global Pleural Disease Therapeutics Market Set to Surpass USD 9.4 Billion by 2033: Future Market Insights Report

The global pleural disease therapeutics market is poised for significant growth, with a projected valuation of USD 9.4 billion by 2033, according to a recently published study by Future Market Insights. Registering a steady CAGR of 6.5% over the next decade, the market is expected to rise from USD 4.98 billion in 2023.

This growth is driven by the increasing prevalence of critical health conditions such as congestive heart failure, lung diseases, pneumonia, cancer, and tuberculosis. As these conditions often lead to pleural effusion—a buildup of fluid in the pleural cavity—the demand for effective treatments and diagnostics is escalating worldwide. Delayed diagnosis of pleural effusion can lead to severe morbidity and mortality, underscoring the urgent need for advanced therapeutic procedures.

Key Drivers of Market Growth:

  1. Rising Incidence of Pleural Effusion-Related Diseases:

Conditions such as systemic lupus erythematosus (30%-50% of patients) and idiopathic pulmonary hypertension (21.5% of patients) exhibit a high association with pleural effusion. This surge in cases is expected to bolster demand for pleural disease therapeutics globally.

  1. Advancements in Diagnosis and Expertise:

Enhanced diagnostic techniques and the availability of skilled healthcare professionals specializing in pleural effusion treatment are pivotal in driving market expansion.

  1. Innovative Product Launches and Strategic Developments:

Leading market players are investing heavily in R&D and strategic collaborations. For instance, in September 2021, BDR Pharma introduced BIAPENEM, a groundbreaking therapeutic solution for treating intra-abdominal infections, lower respiratory infections, and complex urinary tract infections. The drug’s efficacy in penetrating lung tissues and body fluids such as pleural effusion has positioned it as a vital innovation in pleural disease therapeutics.

Future Outlook:

The increasing focus on early diagnosis and innovative treatment solutions is expected to sustain the momentum of the Pleural Disease Therapeutics Market over the forecast period. Additionally, ongoing investments, mergers, and product launches by key industry players will further accelerate market growth.

As healthcare systems worldwide prioritize addressing critical respiratory and cardiac conditions, the demand for advanced pleural disease therapeutics is anticipated to remain robust, positioning this market as a vital component of global healthcare advancements.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Key Takeaways from the Market Study:

  • North America is expected to dominate the industry while reaching market share of around 45% by end of the forecast period
  • The market in Europe is projected to account for 29% market share during the projected timeline
  • By treatment type, thoracentesis is projected to account for 34% market share by end of the forecast period
  • Hospitals are expected to dominate the market by end-user, with a market share of 65 % by 2033
  • Global market for pleural disease therapeutics to reach USD 4.98 billion by the end of 2023

“Adoption of novel drugs and mergers and acquisitions between companies are going to positively influence market of Pleural disease therapeutics during the forecast period,” comments an FMI analyst.

Competitive Landscape:

The Pleural diseases therapeutics market is moderately competitive and consists of various key market players. These players are creating novel delivery systems for treating Pleural diseases. This is anticipated to fuel Pleural diseases therapeutics market. The key players in the market are: WakeMed Health and Hospitals, Boston Medical, Max Healthcare, Avik Pharma, Pfizer CentreOne, Hovione, Pipelinepharma, Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health Companies Inc., Sanofi S.A.

Key market players are focusing on adoption of inorganic growth strategies such as acquisition, partnerships, and collaboration in order to enhance their product portfolio. This is expected to propel the global Pleural diseases therapeutics market.

  • In September 2021, Bristol Mayer Squibb announced three-year data from the Checkmate -743 trial. According to the clinical trial data, serious adverse reactions occurred in almost 54% of patients receiving OPDIVO plus YERVOY. The most frequent serious adverse reactions reported in ≥2% of patients were pneumonia, pyrexia, diarrhea, pneumonitis, pleural effusion, dyspnea, acute kidney injury, infusion-related reaction, musculoskeletal pain, and pulmonary embolism.
  • In January 2020, Argon Medical launched single and triple loop retrieval kits for its U.S. market with the aim to improve lives of patients. The products have managed to secure the approval from the United States Food and Drug Administration, and are efficient in the removal of retrievable IVC filters with the help of a jugular approach. These single and triple loop retrieval kits are the only 2 kits to have received FDA approval in terms of any retrievable IVC filter from a jugular approach.

Key Segments Profiled in the Pleural Diseases Therapeutics Industry Survey:

By Treatment:

  • Drug Class
    • Antibiotics
    • Antifungals
    • Corticosteroids
    • Narcotic Analgesics
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Bullectomy
  • Chemotherapy
  • Video-Assisted Thorascopic Surgery (VATS)
  • PleurX Catheter
  • Pleurodesis Therapy
  • Radiation Therapy
  • Thoracentesis
  • Thoracostomy

By End Users:

  • Hospitals
  • Specialty Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Cardiac Rehabilitation Industry

Flow Diverters Industry

Acid Citrate Dextrose Tubes Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube